Latest news
When Dementia Takes Speech, Trials Must Catch Up
CervoMed has completed enrolment in a Phase IIa study of neflamapimod in nonfluent/agrammatic primary progressive aphasia. The milestone is small, but the unmet need is not.
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
IPM Brief – Issue 11 | Medicine Has Left the Building
KRAS Has a New Contender. It Still Has to Earn Its Place.
Migraine Prevention Gets a Wider Door
Stroke Rehab Cannot Stop at Survival
Disaster Shelters Save Lives. Infection Control Cannot Be Improvised.
Cyclospora Is Spreading. The Food Chain Still Has No Answer.
Indigenous cardiovascular inequity is not a data gap. It is a policy failure
Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.